A Study of Ridinilazole (SMT19969) Compared With Fidaxomicin for the Treatment of Clostridium Difficile Infection (CDI)

Response of Clostridium Difficile Infection to Metronidazole Therapy

NCT00304369 ·Status: COMPLETED

Optimal Treatment for Recurrent Clostridium Difficile

NCT02667418 ·Status: TERMINATED ·Phase: PHASE4

A Study of SMT19969 Compared With Vancomycin for the Treatment of Clostridium Difficile-Associated Diarrhoea (CDAD)

NCT02092935 ·Status: COMPLETED ·Phase: PHASE2

Primary or Recurrent Clostridioides Difficile Infection Treatment With Capsules of Lyophilised Faecal Microbiota vs Fidaxomicin

NCT05201079 ·Status: COMPLETED ·Phase: PHASE3

Evaluation of Fidaxomicin in the Treatment of Clostridium Difficile Infection (CDI)

NCT04070352 ·Status: WITHDRAWN

Rifaximin for Preventing Relapse of Clostridium Associated Diarrhoea

NCT01670149 ·Status: COMPLETED ·Phase: PHASE4

Study to Evaluate the Pharmacokinetics of Fidaxomicin in Inflammatory Bowel Disease (IBD) Subjects With Clostridium Difficile Infection (CDI)

NCT02437591 ·Status: COMPLETED ·Phase: PHASE4

A Trial to Compare Xifaxan to Vancomycin for the Treatment of Clostridium Difficile-Associated Diarrhea (CDAD)

NCT00269399 ·Status: COMPLETED ·Phase: PHASE3

Fidaxomicin Versus Vancomycin for the Treatment of Clostridium Difficile-Associated Diarrhea (CDAD) (MK-5119-018)

NCT00314951 ·Status: COMPLETED ·Phase: PHASE3

Treatment of Recurrent Clostridium Difficile Infection With RBX7455

NCT02981316 ·Status: COMPLETED ·Phase: PHASE1

A Safety, Tolerability and Pharmacokinetic Study of Two Formulations of Metronidazole Versus Immediate Release Metronidazole in Patient With C. Difficile Colitis

NCT01559545 ·Status: COMPLETED ·Phase: PHASE2

MTC Versus FMT in for RCDI

NCT05911997 ·Status: RECRUITING ·Phase: PHASE1

A Post-marketing, Blinded Study to Investigate How Effective Fidaxomicin is Compared to Vancomycin in the Sustained Cure of Clostridium Difficile Infection in Adults That Are Receiving Therapy to Suppress the Immune System

NCT01775397 ·Status: TERMINATED ·Phase: PHASE4

Study to Assess Inhibition of Spore Production in Patients With C. Difficile Infections: Fidaxomicin Versus Vancomycin

NCT01818141 ·Status: COMPLETED ·Phase: PHASE4

Use of Fidaxomicin Compared to Vancomycin for Decolonization of C. Difficile in Patients With Inflammatory Bowel Disease

NCT06794944 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4

A Study of GT160-246 Versus Vancomycin in Patients With Clostridium Difficile-Associated Diarrhea

NCT00034294 ·Status: COMPLETED ·Phase: PHASE2

Study of Nitazoxanide in the Treatment of Clostridium Difficile Colitis

NCT00417872 ·Status: COMPLETED ·Phase: PHASE2

Safety, Tolerability, and Pharmacokinetics of Fidaxomicin in Pediatric Subjects With Clostridium Difficile-associated Diarrhea (CDAD)

NCT01591863 ·Status: COMPLETED ·Phase: PHASE2

Fecal Microbiota Transplant (FMT) Plus Fidaxomicin for Severe or Fulminant Clostridium Difficile Infection

NCT03760484 ·Status: TERMINATED ·Phase: PHASE2

Description of the Use of fidAxomicin in Hospitalized Patients With Documented Clostridium diFficile iNfection and of the managEment of These Patients

NCT02214771 ·Status: COMPLETED

CMTS0929 for Clostridioides Difficile Infection

NCT06836427 ·Status: NOT_YET_RECRUITING ·Phase: EARLY_PHASE1

Prevention of Recurrent Clostridium Difficile Infection (CDI) in Patients With Inflammatory Bowel Disease (IBD).

NCT04626947 ·Status: TERMINATED ·Phase: PHASE4

Fecal Microbiota Transplantation for Relapsing Clostridium Difficile Infection

NCT02743234 ·Status: COMPLETED ·Phase: PHASE3

Study to Assess Safety, Tolerability and Efficacy of Incremental Doses of MGB-BP-3 in Patients With CDAD

NCT03824795 ·Status: COMPLETED ·Phase: PHASE2

A Phase IIIB/IV Study to Compare the Efficacy of Vancomycin Therapy to Extended Duration of Fidaxomicin Therapy in the Clinical Cure of Clostridium Difficile Infection (CDI) in an Older Population

NCT02254967 ·Status: COMPLETED ·Phase: PHASE4